Shots:
• From navigating six cancer diagnoses to building a mission-driven brand, Liz Benditt turned her personal journey into purpose by founding The Balm Box, a company designed to make treatment days a little less overwhelming and a lot more thoughtful for patients and caregivers alike.
• In this CXO Talks episode, we dive into…
Shots:
AI is moving drug development from computation to clinical confidence, showing how it now guides target discovery, molecule design, patient stratification, and trial planning while turning fragmented biomedical data into decision-ready insight that reduces risk, cost, and failure rates.
Trust, transparency, and regulation define AI’s real breakthrough, as the focus shifts beyond speed toward…
Shots:
Amid rising R&D costs and tighter timelines, AI has evolved from a supporting tool to a central driver of biopharma deal-making, discovery strategies, and long-term value creation
AI-led licensing deals, platform partnerships, and new valuation models are reshaping biotech–pharma collaborations, with platforms and proprietary datasets increasingly rivaling or surpassing traditional pipelines in deal value…
In a healthcare environment defined by rapid scientific leaps and rising patient expectations, two influential forces are quietly reshaping the industry’s very foundation: Key Opinion Leaders (KOLs) and Patient Advocacy Groups (PAGs)
Once background contributors, they have emerged as pivotal architects of modern healthcare, steering clinical decisions, shaping scientific narratives, influencing policy, and ensuring that patient voices are not just heard…
Radiopharmaceuticals, once viewed as a niche scientific endeavor, are now revolutionizing the way we detect and treat cancer. By fusing the targeting precision of molecular medicine with the therapeutic strength of radiation, these compounds are unlocking new possibilities in oncology, bringing renewed hope to patients where conventional therapies often fall short
From early detection to…
In this episode of CXO Talks, PharmaShots speaks with Vikas Sharma, Chief Business Officer at QurAlis, a biotech company leading the development of precision medicines for neurodegenerative diseasesÂ
Vikas discusses the company’s FlexASO platform, a next-generation RNA-targeting technology that tackles the root causes of neurological diseasesÂ
Vikas also highlights QurAlis’ lead candidates, QRL-201 and QRL-101,…
Shots:
In this captivating episode of the CXO Talks Podcast, PharmaShots sits down with Josh Wittner, President, North America at Gene By Gene, to explore the company’s evolution and impact in the field of genetic testing
Gene By Gene, a leading commercial genetic testing company, delivers cutting-edge genetic data services spanning a broad range of…
Food is far more than fuel; it transcends nourishment and energy to influence overall health and longevity. The choices we make at the table can help prevent or exacerbate conditions like heart disease, Type 2 diabetes, and certain cancers
A well-balanced diet not only delivers essential nutrients but also strengthens the immune system and supports…
Medical psychedelics are a fascinating field that modern science has yet to comprehend completely. Researchers are still digging up, trying to find evidence-based outcomes to tap into a whole new opportunity in psychiatry and mental health medicines
The September Edition unearths a brand-new perspective on psychedelics through engaging articles, illustrative infographics, trailing BioTrends, illuminating regulatory…
Aesthetic and beauty industry, underplayed by cosmeceuticals, shapes a soaring market worth $312.33B. Cosmeceuticals are known for their medical benefits beyond cosmetics and typically come in the forms of topical creams, serums, and lotions
Let’s unearth the secrets of cosmeceuticals like never before through engaging articles, illustrative infographics, regulatory updates, and much more Â
The…

